?? Big News! ?? As a recipient of the 2023 Project PROTECT grant, FSS has completed the Preparation and Protective phases for a preservative-free Dextrose 70% injection solution. Amidst ongoing drug shortages due to Hurricane Helene and flooding at Baxter’s North Cove site, this milestone supports vulnerable patients, including NICU and PICU babies, have access to essential medications like Dextrose. We're proud to partner with Angels for Change as a protector of Dextrose, supporting patients like those served by the Children’s Hospital Association. "Our partnerships with trusted organizations like CHA and Fagron, are preventing disruptions in care for our nation's most vulnerable patients. I would like to thank them for their commitment to patient care. On average, it takes 12 months to move a PROTECT medicine from selection to production. This vital work is building the supply chain of the future. We must value this work and accelerate it to ensure access to care" said Laura Bray, founder and Chief Change Maker at Angels for Change. Click below to read the full release, including comments from FSS SVP of Commercial Operations, Ray Dixon and FSS SVP of Operations, Jason McGuire. #FagronSterileServices #EndDrugShortagesNOW #ProjectPROTECT
Fagron Sterile Services US (FSS)
制药业
Wichita，KS 3,832 位关注者
503B Pharmaceutical Outsourcing, DEA & FDA-Registered, cGMP Compliant Operations | Boston, MA + Wichita, KS Facilities
关于我们
Fagron Sterile Services US operates two cGMP compliant DEA/FDA-registered and inspected 503B Outsourcing Facilities (Wichita, KS & Boston, MA) delivering a reliable supply sterile of medications to patient-focused healthcare facilities across the United States. FSS specializes in Sterile-to-Sterile, API-to-Sterile, and Biologics, offering an robust portfolio of preparations including ready-to-administer IV bags and OR syringes, pain management, ophthalmics, dialysis, urology, and specialty solutions. OUR STORY: Together we create the future of personalizing medicine. Founded in 1990, in the Netherlands, Fagron engineered one of the largest quality networks, with certified auditors performing supplier qualifications, serving 35 countries, to deliver high-quality products to more than 200,000+ customers worldwide. In doing so, Fagron has become the global leader in pharmaceutical compounding. In 2010, Fagron entered the North American market. As part of the only vertically integrated pharmaceutical company dedicated to sterile compounding, Fagron's 503B facilities (FSS) provide pharmaceutical outsourcing solutions on a comprehensive level to meet customer needs across the continuum of care. As a forward-thinking pharmaceutical supplier, Fagron recognized the opportunity to serve our customers better by acquiring JCB Laboratories, in December, 2013. JCB Labs was at the forefront of shaping industry standards in sterile preparations for nearly two decades and was one of the first companies in the country to register with the FDA. Building off JCB’s experience, Fagron built FSS US, a state-of-the-art manufacturing facility in Wichita, KS, because we believe in the need for regulated sterile preparations. In 2022, Fagron added a second state-of-the-art facility in Boston, MA, through the acquisition of Fresenius Kabi's compounding division. Choose Quality. Choose Consistency. Choose Fagron Sterile Services US, A 503B Outsourcing Solution You Can Rely On!
- 网站
-
https://fagronsterile.com
Fagron Sterile Services US (FSS)的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Wichita，KS
- 类型
- 私人持股
- 创立
- 2002
- 领域
- Sterile Product Compounding、Drug Shortages、503B Outsourcing Facility、ASC Compounding、Hospital Compounding、Anesthesia、Dialysis、Ophthalmology、Pain、Urology、OR Syringes、Adjunct Solutions、Sterile-to-Sterile、API-to-Sterile、Biologics和Pharmaceuticals
地点
Fagron Sterile Services US (FSS)员工
动态
-
?? We're heading to Houston, TX for the ?????????? ???????????????????????????????? ?????????????????????? ???????? ???????????? ??????????????! This event brings together ophthalmologists and healthcare professionals for a robust program focused on advancing patient care. ?Connect with Rocky Brown to learn more about our high-quality ophthalmic solutions and how we support pharmacy needs. ?? See details: https://lnkd.in/gPhQ4TyQ #TOA2025 #Ophthalmology #503B #FagronSterileServices
-
-
???????? ???????? ???????? ???????????????? ???????? ???? ???????? ?????????????????????? ????????????????????? In 503B outsourcing facilities, current Good Manufacturing Practices (cGMP) are the foundation of safety and quality in every medication compounded. At FSS, we adhere to cGMP standards to support the patient care journey by providing high-quality medications to healthcare facilities. From raw material sourcing to final batch testing, FSS meets the strict FDA regulations designed to protect patient care. Read this article for more details ?? https://bit.ly/3Ffrlvk #cGMP #503B #503BOutsourcing #PatientSafety #FagronSterileServices
-
-
Diane Sooter, HR Generalist, shares her FSS experience and the impact she has made through her role over the past six years. From supporting teams across the company to encouraging others, Diane reflects on her journey at FSS and speaks to her favorite Fagron Core Value and Family Rule: Humility and Quality. ? Read more about her experience below. #FSSEmployeeSpotlight #WeAreFagron #FagronSterileServices
-
?? ?????????? ????. ??????????????’?? ?????? ???????? ??????! At FSS, we take pride in supporting healthcare providers nationwide with high-quality, patient-focused solutions. Our commitment goes beyond 503B Outsourcing; we also work toward a greener future. Learn more about Fagron’s global ESG initiatives: https://lnkd.in/g9SDpAiH Wishing you a day filled with luck, good health, and a bit of Irish cheer! #StPatricksDay #WeAreFagron #503B #cGMP
-
-
?? Thank you to everyone who connected with us at the New England Ophthalmological Society (NEOS) meeting. We enjoyed engaging with ophthalmic professionals and sharing how our tailored 503B outsourcing solutions are designed to meet your pharmacy needs. ?? See details about our next event: https://bit.ly/4hx7Dcj
-
-
?? ?????????? ?????????????????????????? ???? ??????! ?? Precision is everything, whether in mathematics or in #503B pharmaceutical outsourcing. Just like the digits of π (3.14) continue infinitely, our commitment to quality and patient care never stops! Every batch we produce undergoes a high-quality process to support patient safety. Visit our website today to learn more about our state-of-the-art facilities and cGMP-compliant operations (fagron.com). #PiDay #InternationalPiDay #WeAreFagron #PatientCare #cGMP
-
-
?? The 144th Indiana Pharmacy Association (IPA) Annual Meeting brought together passionate pharmacy professionals dedicated to advancing the practice. Thanks to everyone who stopped by and connected with our team. ?? Learn more about our next event: https://bit.ly/4hx7Dcj
-
-
?? We're excited to recognize the ASHP Foundation's 2025 Pharmacy Resident Research Grant recipients, who have been awarded a total of $28,752 to further their impactful research. These grants, funded through the ASHP Foundation Joseph A. Oddis Endowment and the Dwight R. Tousignaut Memorial Fund, empower the next generation of pharmacy leaders to tackle critical healthcare challenges related to disease management, medication safety, and access. FSS is a proud corporate partner of the ASHP Foundation and supports research and innovation that drive progress in pharmacy practice and patient care. Learn more ?? https://bit.ly/3FkoJfM
-
-
?? Thank you to everyone who visited us at the ISEPS-COS Joint Conference. We were excited to connect with numerous industry experts and showcase our ophthalmic presentations. ?? If you missed it, see where we’ll be next: https://bit.ly/4hx7Dcj #FagronSterileServices #WeAreFagron #503B #Ophthalmics
-